The nuts and bolts of inhaled nanotherapies

S. Cryan (Dublin, Ireland)

Source: Annual Congress 2013 –Drug delivery to the airways
Session: Drug delivery to the airways
Session type: Symposium
Number: 346
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Cryan (Dublin, Ireland). The nuts and bolts of inhaled nanotherapies. Annual Congress 2013 –Drug delivery to the airways

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
The nuts and bolts of respiratory muscle testing
Source: Annual Congress 2011 - PG8 Assessing respiratory muscle strength: an interactive course
Year: 2011

Occupational asthma in a sample of herbal and fruit tea processors
Source: Annual Congress 2007 - From environmental tobacco smoke and wood smoke at home to herbal tea at work
Year: 2007

Respiratory and neurological risks due to toxic and irritant gases in imported fright containers and goods
Source: Annual Congress 2008 - Asthma and inhalation injuries at work
Year: 2008

Inhaled therapies: plastics, propellants, and pollutants
Source: Virtual Congress 2021 – Environment, air pollution, health and respiratory disease
Year: 2021

Plume spray force of three HFA-propelled ICS/LABA combination inhalers
Source: International Congress 2017 – Pulmonary drug and devices delivery
Year: 2017

Use of dry powder inhalers in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 286s
Year: 2005

Equivalence testing of salbutamol dry powder inhalers by in vitro impaction
Source: Eur Respir J 2001; 18: Suppl. 33, 100s
Year: 2001

Bronchodilator responses of a cup of tea in asthmatic subjects
Source: Eur Respir J 2006; 28: Suppl. 50, 314s
Year: 2006

Flocking, popcorn and an ingested Asian shrub (Sauropus androgynus)
Source: Annual Congress 2006 - PG3 - Update on occupational and environmental lung disease, including "bring your own cases" for interactive discussion
Year: 2006

Comparison of the in vitro performance of originator and generic drug-combination dry powder inhalers
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013

Inhaler treatment options in COPD
Source: Eur Respir Rev 2005; 14: 102-108
Year: 2005

Cereal allergy
Source: Eur Respir J 2006; 28: Suppl. 50, 678s
Year: 2006

Airway obstruction related to diacetyl exposure at microwave popcorn production facilities
Source: Eur Respir J 2009; 34: 63-71
Year: 2009

Bronchiolitis obliterans syndrome in popcorn production plant workers
Source: Eur Respir J 2004; 24: 298-302
Year: 2004

Reliability of inhalation therapy through a multidose dry powder inhaler
Source: Annual Congress 2007 - Respiratory issues in primary care
Year: 2007

Acceptability of two dry powder inhalers in 645 asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 338s
Year: 2005

Handling and patient preference of dry powder inhalers for asthma and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 210s
Year: 2006

Never mind the biologics, just take the inhalers
Source: Breathe, 14 (3) 176; 10.1183/20734735.021118
Year: 2018

Talcosis due to abundant use of cosmetic talcum powder
Source: Eur Respir Rev 2009; 19: 165-168
Year: 2010